+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Telecare Market Size, Share & Industry Trends Analysis Report By Product Type, By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 78 Pages
  • March 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5590206
The North America Telecare Market is expected to witness market growth of 4.3% CAGR during the forecast period (2021 2027).

Telemedicine, or telecare, is the virtual delivery of healthcare services over telecommunications infrastructures, such as tests and consultations. Numerous companies have already initiated or deployed telemedicine initiatives. Even small and independent medical practices are beginning to use telemedicine as an effort to cope with local retail clinics and avoid losing patients. Healthcare facilities can receive several benefits by leveraging telemedicine features. Moreover, it has the potential to increase efficiency and profitability, along with improving patient access to medical services. This factor is expected to facilitate the penetration of telecare services
Telecare solutions are considered beneficial in improving health outcomes while also lowering costs. When compared to traditional approaches, telecare services save money for patients, providers, as well as market players. Telemedicine has lowered healthcare costs while boosting efficiency with better chronic illness management, shorter travel times, pooled healthcare professional staffing, and reduced hospital stays. As a result of all of these factors, the telecare market is anticipated to grow significantly over the forecast period.

Telecare is a rapidly developing aspect of healthcare across the United States, owing to the country's high adoption of innovative healthcare technologies and the rising burden of chronic diseases. Telecare has enhanced care management, improved patients' quality of life, as well as significantly reduced healthcare costs. Moreover, according to the data shared by the National Library of Medicines, Chronic wounds are estimated to affect 2% of the population in the United States. Chronic wounds cause a negative impact on people all around the world. According to a 2016 research from Wales, chronic wounds affect 6% of the population, costing the NHS 5.5 percent of its budget.

The US market dominated the North America Telecare Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $1,411.1 million by 2027. The Canada market is poised to grow at a CAGR of 6.6% during (2021 - 2027). Additionally, The Mexico market is expected to exhibit a CAGR of 5.7% during (2021 - 2027).

Based on Product Type, the market is segmented into Activity Monitoring and Remote Medication Management. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, AllScripts Healthcare Solutions, Inc., AT&T, Inc., Samsung Electronics Co., Ltd., Apple, Inc., Qualcomm, Inc., and Google LLC.

Scope of the Study


Market Segments Covered in the Report:


By Product Type

  • Activity Monitoring
  • Remote Medication Management

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players


List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Pfizer, Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • AllScripts Healthcare Solutions, Inc.
  • AT&T, Inc.
  • Samsung Electronics Co., Ltd.
  • Apple, Inc.
  • Qualcomm, Inc.
  • Google LLC

Unique Offerings from the publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Telecare Market, by Product Type
1.4.2 North America Telecare Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Publisher Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2020, Mar - 2021, Dec) Leading Players
Chapter 4. North America Telecare Market by Product Type
4.1 North America Activity Monitoring Market by Country
4.2 North America Remote Medication Management Market by Country
Chapter 5. North America Telecare Market by Country
5.1 US Telecare Market
5.1.1 US Telecare Market by Product Type
5.2 Canada Telecare Market
5.2.1 Canada Telecare Market by Product Type
5.3 Mexico Telecare Market
5.3.1 Mexico Telecare Market by Product Type
5.4 Rest of North America Telecare Market
5.4.1 Rest of North America Telecare Market by Product Type
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Pfizer, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.3 Sanofi S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Johnson and Johnson
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental &Regional Analysis
6.4.4 Research & Development Expenses
6.5 AllScripts Healthcare Solutions, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 AT&T, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Samsung Electronics Co., Ltd. (Samsung Group)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Product Launches and Product Expansions:
6.7.6 SWOT Analysis
6.8 Apple, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Product and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.6 SWOT Analysis
6.9 Qualcomm, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.9.5 SWOT Analysis
6.10. Google LLC
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expense
6.10.5 Recent strategies and developments:
6.10.5.1 Partnerships, Collaborations, and Agreements:
6.10.6 SWOT Analysis

Companies Mentioned

  • Abbott Laboratories
  • Pfizer, Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • AllScripts Healthcare Solutions, Inc.
  • AT&T, Inc.
  • Samsung Electronics Co., Ltd.
  • Apple, Inc.
  • Qualcomm, Inc.
  • Google LLC

Methodology

Loading
LOADING...